Z
Zhibin Xie
Researcher at Wuhan University of Science and Technology
Publications - 2
Citations - 999
Zhibin Xie is an academic researcher from Wuhan University of Science and Technology. The author has contributed to research in topics: Population & Hydroxychloroquine. The author has an hindex of 2, co-authored 2 publications receiving 859 citations.
Papers
More filters
Journal ArticleDOI
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial.
Wei Tang,Zhujun Cao,Mingfeng Han,Zhengyan Wang,Junwen Chen,Wenjin Sun,Yaojie Wu,Wei Xiao,Shengyong Liu,Erzhen Chen,Wei Chen,Xiongbiao Wang,Jiuyong Yang,Jun Lin,Qingxia Zhao,Youqin Yan,Zhibin Xie,Dan Li,Yaofeng Yang,Leshan Liu,Jieming Qu,Guang Ning,Guochao Shi,Qing Xie +23 more
TL;DR: Administration of hydroxychloroquine did not result in a significantly higher probability of negative conversion than standard of care alone in patients admitted to hospital with mainly persistent mild to moderate covid-19, and adverse events were higher in hydroxy chloroquine recipients than in non-recipients.
Posted ContentDOI
Hydroxychloroquine in patients mainly with mild to moderate COVID–19: an open–label, randomized, controlled trial
Wei Tang,Zhujun Cao,Mingfeng Han,Zhengyan Wang,Junwen Chen,Wenjin Sun,Yaojie Wu,Wei Xiao,Shengyong Liu,Erzhen Chen,Wei Chen,Xiongbiao Wang,Jiuyong Yang,Jun Lin,Qingxia Zhao,Youqin Yan,Zhibin Xie,Dan Li,Yaofeng Yang,Leshan Liu,Jieming Qu,Guang Ning,Guochao Shi,Qing Xie +23 more
TL;DR: The administration of HCQ did not result in a higher negative conversion rate but more alleviation of clinical symptoms than SOC alone in patients hospitalized with COVID-19 without receiving antiviral treatment, possibly through anti-inflammatory effects.